No account yet? Register.
Pneumococcal Polysaccharide Vaccine Print
Recommendation for Immunization
Age:
How often:
65+
Once

Note:
Some people may need a second dose, check with your doctor.

Vaccination recommended for age range 2-65 if:

  • Race: Alaskan Native, Native American Indian
  • Resident of long-term care facility
  • Diabetes
  • Chronic lung problem (not asthma)
  • Chronic cardiovascular disease
  • Chronic liver disease including alcohol related liver disease
  • Chronic alcoholism
  • Chronic kidney failure or nephrotic syndrome
  • Missing or damaged spleen
  • HIV
  • Impaired immunity, including that caused by chemotherapy or radiation
  • Sickle cell anemia
  • Certain cancers including: leukemia, lymphoma, multiple myeloma, Hodgkin’s, organ or marrow transplant, advanced cancer
  • Cochlear implants
  • Cerebrospinal fluid (CSF) leak

1. What is this vaccine?

This is a vaccine against serious illnesses caused by 23 different strains of Streptococcus pneumoniae bacteria (also called pneumococcus).


2. Why is this vaccine important?

This vaccine, available as Pneumovax® 23, offers protection against many strains of pneumococcal pneumonia, blood infection, or meningitis, all very serious and potentially life-threatening forms of infection caused by the bacterium Streptococcus pneumoniae.


3. How is this vaccine given?

It is given as an injection into the subcutaneous or intramuscular tissue of the deltoid muscle or lateral mid-thigh.


4. What are the risks and special considerations of this vaccine?

You may experience redness or pain at the injection site: this occurs about half of the time. About 1% of people develop fever, muscle aches, or more of a reaction at the injection site. Remember to check with your doctor if you need to get a second dose. It is unclear if this vaccine is safe during pregnancy and breastfeeding. If you are going to undergo treatment like chemotherapy that will suppress your immune system, the timing of the vaccine beforehand can be very important; discuss this with your doctor. It is considered safe to administer this vaccine at the same time as the influenza vaccine as long as it is given in the other arm.

Individuals with prior severe reactions to this vaccine may not be able to receive another dose. Check with your doctor regarding this issue and for any other contraindications for this vaccine. Also check with your doctor to find out what other ingredients may be in the vaccine, its container, or any diluent in case of allergies or other concerns. Immunization is usually postponed for individuals with a moderate or severe acute illness.


5. Risk factors for contraction of disease

  • Age >/= 65
  • Chronic kidney, lung, liver, or cardiovascular disease
  • Diabetes
  • No spleen or non-functioning spleen
  • Sickle cell anemia
  • Leukemia, lymphoma, Hodgkin’s disease, multiple myeloma, advanced cancer, organ or marrow transplant
  • Immune suppression from chemotherapy, radiation therapy
  • Cochlear implant
  • Resident of long-term care facility
  • Cerebrospinal fluid (CSF) leak
  • Native Alaskan and some Native American


Citations

  1. "Preventive Screening Tests and Immunizations." U.S. Department of Health and Human Services. November 2007. www.4woman.gov/screeningcharts/general/.
  2. "Preventive Screening Tests and Immunizations." U.S. Department of Health and Human Services. June 2007. www.4woman.gov/screeningcharts/men/.
  3. "Recommended Immunization Schedule for Persons Aged 0-18 Years, United States 2008." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. May 2008. http://www.cdc.gov/vaccines/recs/schedules/downloads/child/2008/08_11x17_booklet_pr.pdf.
  4. "Recommended Adult Immunization Schedule — United States, October 2007–September 2008." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. October 2007. www.cdc.gov/mmwr/pdf/wk/mm5641-Immunization.pdf.
  5. "Pneumococcal Polysaccharide Vaccine." Medline Plus. A Service of the U.S. National Library of Medicine and the National Institutes of Health. October 2006. www.nlm.nih.gov/medlineplus/ency/article/002029.htm.
  6. "Pneomococcal (7/29/97)Vaccine Information Statement." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. National Immunization Program. www.cdc.gov/vaccines/pubs/vis/downloads/vis-ppv.pdf.
  7. "Pneumovax® 23 (Pneumococcal Vaccine Polyvalent)." Merck and Co, Inc. July 2008. www.merck.com/product/usa/pi_circulars/p/pneumovax_23/pneumovax_pi.pdf.
  8. "Vaccine Excipient and Media Summary." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-1.pdf.
  9. "Vaccine Excipient and Media Summary, Part 2." U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. April 2008. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-2.pdf.
  10. "Thimerosol in Vaccines." U.S. Food and Drug Administration. Center for Biologics Evaluation and Research. June 2007. http://www.fda.gov/cber/vaccine/thimerosal.htm.

Created: 7/2/2007
Last Modified: 8/12/2008
 
© 2008 Health Butler, LLC
Terms and Conditions, Privacy Policy